Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EMBC - Embecta Corp.


IEX Last Trade
20.755
0.155   0.747%

Share volume: 4,754
Last Updated: Fri 27 Dec 2024 08:30:39 PM CET

PREVIOUS CLOSE
CHG
CHG%

$20.60
0.16
0.75%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
2.16%
1 Month
1.17%
3 Months
47.10%
6 Months
67.17%
1 Year
10.39%
2 Year
-22.36%
Key data
Stock price
$20.76
P/E Ratio 
13.53
DAY RANGE
$20.36 - $20.70
EPS 
$1.20
52 WEEK RANGE
$10.33 - $21.48
52 WEEK CHANGE
$10.04
MARKET CAP 
942.848 M
YIELD 
3.56%
SHARES OUTSTANDING 
57.702 M
DIVIDEND
$0.15
EX-DIVIDEND DATE
08/27/2024
NEXT EARNINGS DATE
11/19/2024
BETA 
1.47
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$533,287
AVERAGE 30 VOLUME 
$472,314
Company detail
CEO: Devdatt Kurdikar
Region: US
Website: embecta.com
Employees: 1,900
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Embecta Corp. focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications. The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Recent news